in

Polatuzumab-Based Combination Continues to Impress in Real-World DLBCL Analyses

Source link : https://newshealth.biz/health-news/polatuzumab-based-combination-continues-to-impress-in-real-world-dlbcl-analyses/

(MedPage Today) — At the recent American Society of Hematology annual meeting, real-world analyses examined how polatuzumab vedotin (Polivy) with rituximab, cyclophosphamide, doxorubicin, and prednisone (pola-R-CHP) is being adopted outside of… Source link : https://www.medpagetoday.com/meetingcoverage/ashfuturefocusdlbcl/119127 Author : Publish date : 2025-12-22 15:55:00 Copyright for syndicated content belongs to the linked Source.

The post Polatuzumab-Based Combination Continues to Impress in Real-World DLBCL Analyses first appeared on News Health.

—-

Author : News Health

Publish date : 2025-12-22 15:55:00

Copyright for syndicated content belongs to the linked Source.

—-

12345678

Discover the Ultimate Summer Road Trip Destination You Never Saw Coming

Azerbaijan and US Explore New Opportunities for Healthcare Collaboration